Chrysene
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Chrysene
UNSPSC Description:
Chrysene is a high molecular weight (HMW), polycyclic aromatic hydrocarbon (PAH) known for its recalcitrance and carcinogenic properties[1].Target Antigen:
Biochemical Assay ReagentsType:
Natural ProductsRelated Pathways:
OthersApplications:
Cancer-programmed cell deathField of Research:
CancerAssay Protocol:
https://www.medchemexpress.com/chrysene.htmlPurity:
99.81Solubility:
DMSO : 2 mg/mL (ultrasonic;warming;heat to 60°C)Smiles:
C12=CC=CC=C1C=CC3=C4C=CC=CC4=CC=C23Molecular Weight:
228.29References & Citations:
[1]Vaidya S, et al. Degradation of Chrysene by Enriched Bacterial Consortium. Front Microbiol. 2018 Jun 26;9:1333.|[2]Wislocki PG, et al. Tumorigenicity of nitrated derivatives of pyrene, benz[a]anthracene, chrysene and benzo[a]pyrene in the newborn mouse assay. Carcinogenesis. 1986 Aug;7(8):1317-22.|[3]Jacob J, et al. Monooxygenase induction by various xenobiotics and its influence on rat liver microsomal metabolism of chrysene in comparison to benz[a]anthracene. Cancer Lett. 1987 Jan;34(1):91-102.|[4]Tao LP, et al. Chrysene, a four-ring polycyclic aromatic hydrocarbon, induces hepatotoxicity in mice by activation of the aryl hydrocarbon receptor (AhR). Chemosphere. 2021 Aug;276:130108.|[5]Hodgson RM, et al. Metabolic activation of chrysene in mouse skin: evidence for the involvement of a triol-epoxide. Carcinogenesis. 1983 Dec;4(12):1639-43.|[6]Rice JE, et al. Comparative tumor-initiating activity of methylene-bridged and bay-region methylated derivatives of benz[a]anthracene and chrysene. Carcinogenesis. 1988 Dec;9(12):2275-8.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Clinical Information:
No Development ReportedCAS Number:
218-01-9
